HomeORY • BME
add
Oryzon Genomics SA
Previous close
€2.84
Day range
€2.80 - €2.88
Year range
€2.43 - €4.02
Market cap
228.08M EUR
Avg Volume
372.87K
P/E ratio
-
Dividend yield
-
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 10.93M | 48.59% |
Operating expense | 4.85M | 173.07% |
Net income | -1.35M | -20.22% |
Net profit margin | -12.33 | 19.09% |
Earnings per share | -0.02 | 11.91% |
EBITDA | 5.83M | 9.74% |
Effective tax rate | 68.94% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 28.37M | 404.91% |
Total assets | 144.52M | 31.57% |
Total liabilities | 26.68M | 23.07% |
Total equity | 117.85M | — |
Shares outstanding | 77.51M | — |
Price to book | 1.87 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -1.35M | -20.22% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2000
Website
Employees
44
